Nothing comparable since the round — shown at its Series A, Oct 2024 ($285.5M post-money).
- ·2 fund marks: filer, period, implied $/share
Membership and data by Private Market View
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
City Therapeutics funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Oct 2024 | Early Stage VC (Series A) | $135.0M | ▮ | ▮ |
Membership and data by Private Market View
City Therapeutics valuation
City Therapeutics is valued at approximately $285 million as of Oct 2026. The figure is set by institutional fund marks. The reference point is its Series A in Oct 2024, at a $285 million post-money valuation.
Recent activity
In the last 90 days, City Therapeutics's record added 1 institutional fund mark (latest period Jul 2026).
How much has City Therapeutics raised?
City Therapeutics has raised $140 million across 1 recorded round since 2024. The largest was a $135 million Series A in Oct 2024.
Institutional holders and vehicles
2 SEC-registered funds reported 2 fair-value marks on City Therapeutics between May 2026 and Jul 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.
Comparable companies
Comparable drug discovery names by valuation on PrivateMarketView: Mythic Therapeutics ($293 million), Convergent Therapeutics ($280 million) and Ensoma ($280 million).
How City Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For City Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by institutional fund marks. Question about this number? Full methodology →
Frequently asked about City Therapeutics
- What is City Therapeutics worth?
- City Therapeutics is valued at $285.5M as of Oct 2026. Nothing comparable since the round — shown at its Series A, Oct 2024 ($285.5M post-money).
- How much has City Therapeutics raised?
- City Therapeutics has raised $139.5M in total funding across 1 recorded rounds.
- When did City Therapeutics last raise?
- City Therapeutics last raised in Oct 2024 (Early Stage VC (Series A)), raising $135.0M.